Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Encore PFO Closure Device U.S. IDE Randomized Trial - The PerFOrm Trial

NCT05537753 is registered in ClinicalTrials.gov with Encore Medical Inc. as lead sponsor.

NCT NCT05537753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05537753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Encore PFO Closure Device U.S. IDE Randomized Trial - The PerFOrm Trial
Lead sponsor
Encore Medical Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
July 12, 2023
Completion date
October 31, 2030
Enrollment
500 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cryptogenic stroke, patent foramen ovale